SCHEMBL5608451

SCHEMBL5608451

CCC1CCc2ccccc2C1=O

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.59
ACHE P22303 3/20 0.54
HTR1A P08908 2/20 0.54
SIGMAR1 Q99720 2/20 0.54
ALDH1A1 P00352 2/20 0.50
METAP1 P53582 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTR2C P28335 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15700140 0.90 ACHE (0.56) CYP19A1ACHEHTR1ASIGMAR1METAP1
Pyruvate SCHEMBL7525474 0.89 CYP19A1 (0.53) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL8756180 0.83 CYP19A1 (0.58) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL11635436 0.82 CYP19A1 (0.52) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL6272342 0.82 CYP19A1 (0.57) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL6307397 0.82 CYP19A1 (0.59) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL11734950 0.82 CYP19A1 (0.59) CYP19A1ACHEHTR1ASIGMAR1ALDH1A1
SCHEMBL866816 0.81 METAP1 (0.67) CYP19A1ACHEHTR1ASIGMAR1METAP1
SCHEMBL8003063 0.81 METAP1 (0.71) CYP19A1ACHEHTR1ASIGMAR1METAP1
SCHEMBL2125675 0.81 METAP1 (0.71) CYP19A1ACHEHTR1ASIGMAR1METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014068341-A2 CHIRAL FLUORINATING REAGENTS ISIS INNOVATION LIMITED (GB) 2014-05-08 WO disclosed
US-20080103176-A1 Substituted Hydroxyethylamines PFIZER INC. 2008-05-01 US disclosed
EP-1354887-B1 Ligands for metals and improved metal-catalyzed processes based thereon MASSACHUSETTS INST TECHNOLOGY (US) 2007-04-25 EP disclosed
EP-1097158-B1 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INST TECHNOLOGY (US) 2006-01-25 EP disclosed
US-6867310-B1 Arylation and vinylation of activated carbons MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-03-15 US disclosed
EP-1354887-A1 Ligands for metals and improved metal-catalyzed processes based thereon Massachusetts Insitute of Technology (US) 2003-10-22 EP disclosed
EP-1097158-A2 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-05-09 EP disclosed
WO-2000002887-A2 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2000-01-20 WO disclosed
US-4504663-A ANALGESIC, ANTIDEPRESSANT DELALANDE S.A. (FR) 1985-03-12 US disclosed
US-4431851-A ANALGESICS, ANTIDEPRESSANTS DELALANDE S.A. (FR) 1984-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103176-A1 Substituted Hydroxyethylamines BACE1, BACE2, PSEN1 CYP19A1 195/4885ACHE 34/4885HTR1A 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.